Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Experimental and Molecular Therapeutics 14: Gene and Vector-based Therapy 1

Loss of DNA mismatch repair proficiency increases ganciclovir cytotoxicity

Jessica J. O’Konek, Paul D. Boucher and Donna S. Shewach
Jessica J. O’Konek
University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul D. Boucher
University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna S. Shewach
University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2006
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 47, 2006

Abstract

2098

Engineering tumor cells to express the herpes simplex virus type 1 thymidine kinase (HSV-TK) allows the normally innocuous antiviral, GCV, to be phosphorylated to its triphosphate, which elicits cytotoxicity following its incorporation into DNA. Previously we have reported that GCV cytotoxicity can be enhanced by the addition of hydroxyurea (HU), a ribonucleotide reductase inhibitor that produces an imbalance in dNTP pools, resulting in additive cytotoxicity in HSV-TK-expressing cells and synergistic cytotoxicity in bystander cells in a wide variety of solid tumor cell lines. Because HU causes an imbalance in dNTP pools and activates the mismatch repair pathway (MMR), this study aimed to determine if MMR affects sensitivity to GCV. In these studies we used two HCT116 colon carcinoma cell lines which are matched for MMR proficiency and deficiency. The parental HCT116 0-1 are MMR deficient due to the mutation of an essential gene for MMR, hMLH1, whereas HCT116 1-2 stably express MLH1 and are MMR proficient. We have generated stably expressing HSV-TK clones of these two cell lines. Cell survival studies performed after a 24 hr incubation with GCV demonstrated that HCT116 0-1TK cells were significantly more sensitive to GCV than HCT116 1-2TK cells (IC50 = 0.1 μM and 0.2 μM, IC90 = 0.7 μM and 1.3 μM, respectively; p<0.05). To verify that the differences in GCV cytotoxicity observed in the HSV-TK clones were not due to selection of clones with variable expression of TK, we treated parental HCT116 0-1 and 1-2 (non-HSV-TK expressing) with high concentrations of GCV, assuming GCV metabolism by endogenous kinases would be similar at the high concentrations in each cell line. The MMR deficient HCT116 0-1 were significantly more sensitive to GCV than the MMR proficient HCT116 1-2 (IC50= 124 μM and 465 μM, respectively; p<0.01) validating the results observed in the HSV-TK expressing cells. To further evaluate the effect of MMR proficiency on GCV cytotoxicity, siRNA was utilized to decrease expression of hMLH1 in HSV-TK expressing U251 human glioblastoma and SW480 human colon carcinoma cells, both of which are considered MMR proficient cell lines. Suppression of hMLH1 resulted in increased sensitivity to GCV in both cell lines. Taken together, these data suggest that MMR may play a role in sensing or repairing GCV incorporation into DNA.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 66 (8 Supplement)
April 2006
Volume 66, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Loss of DNA mismatch repair proficiency increases ganciclovir cytotoxicity
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Loss of DNA mismatch repair proficiency increases ganciclovir cytotoxicity
Jessica J. O’Konek, Paul D. Boucher and Donna S. Shewach
Cancer Res April 15 2006 (66) (8 Supplement) 495;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Loss of DNA mismatch repair proficiency increases ganciclovir cytotoxicity
Jessica J. O’Konek, Paul D. Boucher and Donna S. Shewach
Cancer Res April 15 2006 (66) (8 Supplement) 495;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Oncolytic HSV replication is independent of proliferative state of glioma cells
  • Development of gene vectors for pinpoint targeting to human hepatocytes by cationically modified polymer complexes
  • An antisense oligonucleotide targeting the heavy chain of ferritin can synergistically increase the antitumor activity of rTNFa against the MCF-7 human breast cancer cell line
Show more Experimental and Molecular Therapeutics 14: Gene and Vector-based Therapy 1
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement